(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KAWIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

KAWIN

ST13

US500000090820177

Class

5, 42

Filing

90820177

Registration

6802387

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

9

Latest update

07/26/2022

Trademark type

Combined

Nice classes

5, 42

Filing date

07/09/2021

Registration date

07/26/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/26/2022

Last transaction

07/26/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

16

Owner location

Yizhuang Beijing, CN

Examiner

ELTON, DAVID JONATHAN

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word Kawin in stylized letters.

Holders and representatives

Holders

Beijing Kawin Technology Share-Holding Co., Ltd.

Representatives

TIMOTHY H. HIEBERT WOMBLE BOND DICKINSON (US) LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceuticalsanti-infectives; Vaccines; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Chemical preparations for sanitary purposes; Pharmaceutical preparations for the prevention and treatment of cancer and tumors; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparationsanticoagulants; Reagent paper for medical purposes; Diagnostic preparations for medical purposes; Medical diagnostic reagent

Class 42

Pharmaceutical research services; Technological consulting services in the field of technology developmentin the field of developing biotechnology processes and procedures; Pharmaceutical drug development services; Drug research services; Development of pharmaceutical preparations and medicines; Chemical research; Conducting early evaluations in the field of new pharmaceuticals; Biological research and analysis; Biological research; Research and development services in the field of antibodies

Publications

History of USPTO decisions and trademark events.

9 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/26/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/26/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/10/2022

PUBO

PUBLISHED FOR OPPOSITION

05/10/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/20/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/04/2022

DOCK

ASSIGNED TO EXAMINER

03/28/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/16/2021

NWAP

NEW APPLICATION ENTERED

07/13/2021

Continuous trademark protection

Get notified about every new filing that threatens KAWIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.